Matthew C Hill insider trades: Apyx Medical (APYX) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Matthew reports to the SEC
Open-market buys and sales
7 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 13, 2024 | APYX | ↑ Buy | 5,336 | $1.13 | $6K | Direct | Aug 13, 2024 (0d) |
| Dec 12, 2023 | APYX | ↑ Buy | 2,500 | $2.19 | $5K | Direct | Dec 14, 2023 (2d) |
| Dec 13, 2021 | PDSB | ↑ Buy | 2,900 | $8.99 | $26K | Direct | Dec 14, 2021 (1d) |
| Dec 13, 2021 | PDSB | ↑ Buy | 100 | $9.00 | $900 | Daughter | Dec 14, 2021 (1d) |
| Dec 13, 2021 | PDSB | ↑ Buy | 100 | $9.00 | $900 | Son | Dec 14, 2021 (1d) |
| Jun 14, 2018 | SSKN | ↑ Buy | 10,000 | $1.96 | $20K | Direct | Jun 14, 2018 (0d) |
| May 28, 2008 | VLCR | ↑ Buy | 9,000 | $0.40 | $4K | Direct | May 28, 2008 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Matthew C Hill's insider trades
Matthew C Hill is Chief Financial Officer at Apyx Medical (APYX). Since May 28, 2008, Matthew has reported 7 open-market purchases worth $63K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (13 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every APYX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.